This study is done to investigate the pain relieving effects of the study drug Gralise (a
novel long acting gabapentinoid) for people who experience chronic pelvic pain. Subjects with
Irritable Bowel Syndrome, Interstitial Cystitis, Ulcerative Colitis, and Prostatitis will be
recruited. The purpose of this research is to look at how the study drug can be used to
benefit people who experience this type of pain. This is a phase IV study done to study the
safety and effectiveness of the drug. At this point the drug has been approved by the Food
and Drug Administration and has been reported to be well tolerated and effective in the
treatment of various chronic pain conditions, particularly in neuropathic pain. About 36
subjects will take part in this study.
Phase:
Phase 4
Details
Lead Sponsor:
Rehabilitation Institute of Chicago Shirley Ryan AbilityLab